Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Core EBITDA Margin

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Core EBITDA Margin(%) 11.358.879.128.968.98

What is the latest Core EBITDA Margin ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Core EBITDA Margin ratio of SYNCOM FORMULATIONS (INDIA) is 11.35 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202411.35
Mar20238.87
Mar20229.12
Mar20178.96
Mar20168.98

How is Core EBITDA Margin of SYNCOM FORMULATIONS (INDIA) Trending?

Years Core EBITDA Margin % Change
Mar2024 11.35
27.96
Mar2023 8.87
-2.74
Mar2022 9.12
1.79
Mar2017 8.96
-0.22
Mar2016 8.98 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Core EBITDA Margin ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,951.4 Cr -4.8% 34.2% 76.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4.8%

34.2%

76.8%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses